Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Integrated Islet Distribution Program (UC4)
The NIDDK plans to continue funding the Integrated Islet Distribution Program at City of Hope, which provides human islets to researchers for diabetes studies.
Funder: National Institutes of Health
Due Dates: September 30, 2026 (Full application deadline)
Funding Amounts: Up to $2,200,000 per award; estimated total program funding is $3,300,000; 1 expected award.
Summary: Supports the continuation of the Integrated Islet Distribution Program to provide human islet resources for diabetes research.
Key Information: Single source opportunity—only Beckman Research Institute/City of Hope (current awardee) is eligible.
Description
This funding opportunity supports the renewal and continuation of the Integrated Islet Distribution Program (IIDP), a resource that provides human islets to the biomedical research community to advance diabetes research. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to issue a single source cooperative agreement to the Beckman Research Institute/City of Hope, which currently manages the IIDP. The program’s mission is to facilitate the distribution of human islets by partnering with qualified islet isolation facilities, managing investigator eligibility, and overseeing standardized analyses of islet preparations. The IIDP is a critical resource for understanding human islet cell biology and developing new therapies for the prevention and treatment of diabetes. This initiative is associated with the Special Diabetes Program, which focuses on type 1 diabetes research and its complications.
